XOventure International

XOventure GmbH

Fliederweg 4

CH-6353 Weggis

UID: CHE-205.385.642

Phone Book:
Jørgen Thorball	+41 7864 82777	This e-mail address is being protected from spambots. You need JavaScript enabled to view it	thorball
Betina Thorball	+41 7863 09054	This e-mail address is being protected from spambots. You need JavaScript enabled to view it	rufula_skype
Øystein Rist	+45 4248 1806	This e-mail address is being protected from spambots. You need JavaScript enabled to view it	oystein_rist
Dagmar Beck	+45 2289 3393	This e-mail address is being protected from spambots. You need JavaScript enabled to view it	dagmar.beck1
Morten Albrechtsen	+45 2425 6266	This e-mail address is being protected from spambots. You need JavaScript enabled to view it	malbrechtsen
Thomas Beck	+45 4015 2121	This e-mail address is being protected from spambots. You need JavaScript enabled to view it	newdirections1
John Reddington	+1 2037 224181	This e-mail address is being protected from spambots. You need JavaScript enabled to view it	john.j.reddington
Maurice Cary	+41 7947 49525	This e-mail address is being protected from spambots. You need JavaScript enabled to view it	caryconsulting

Last Updated on Thursday, 15 September 2011 10:50

COURSE

Drug Development:

Challenges & Solutions

May 23-25, 2011, Copenhagen

Pathology Experts

in collaboration with XOventure

More information

_____________

XOventure opens

new Copenhagen office:

Bagsværdvej 70A

DK-2800 Lyngby

Opening Reception

Feb 4, 2011

_____________

Managing Partner

Jørgen Thorball

receives Medicon Valley

Cross-Border Award

Oct 28, 2010

ReadXOventure GmbH established in Lucerne, central Switzerland!

Dec 2011:
2nd Drug Development Course
Registration open!
Pathology Experts & XOventure.
More Information

Nov 2011:
Entrepreneur of the Year
Immudex, a management buy-out from Dako led by XO win Ernst & Young's "Entrepreneur of the Year" 2011!

July 2011: XOventure GmbH
XOventure GmbH established in Lucerne, central Switzerland!

May 2011:
Success with course!
Drug Development:
Challenges & Solutions
Pathology Experts & XOventure.